Similar articles for PMID: 14660711

Year	Number of Results
1879	1
1961	2
1962	1
1968	1
1971	1
1974	1
1975	3
1976	4
1977	4
1978	4
1980	2
1981	3
1982	3
1983	5
1984	8
1985	8
1986	8
1987	17
1988	16
1989	12
1990	12
1991	11
1992	8
1993	12
1994	11
1995	16
1996	19
1997	8
1998	14
1999	14
2000	9
2001	19
2002	17
2003	18
2004	12
2005	7
2006	12
2007	6
2008	7
2009	9
2010	6
2011	7
2012	14
2013	7
2014	5
2015	10
2016	7
2017	15
2018	9
2019	11
2020	9
2021	7
2022	5
2023	2
2024	0

1

Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.

Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. Okazawa H, et al. J Nucl Med. 2003 Dec;44(12):1875-83. J Nucl Med. 2003. PMID: 14660711 Free article. Clinical Trial.

2

Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.

Okazawa H, Yamauchi H, Sugimoto K, Takahashi M. Okazawa H, et al. J Nucl Med. 2003 Sep;44(9):1371-8. J Nucl Med. 2003. PMID: 12960179 Free article. Clinical Trial.

3

PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.

Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Fukumura T, Masuda K, Fujii K, Fukui M. Kuwabara Y, et al. J Nucl Med. 1998 May;39(5):760-5. J Nucl Med. 1998. PMID: 9591570 Free article.

4

Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.

Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Yamauchi H, et al. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1349-56. doi: 10.1007/s00259-002-0899-x. Epub 2002 Aug 6. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271418 Clinical Trial.

5

Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.

Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, Tamaki N, Iwasaki Y. Kuroda S, et al. J Nucl Med. 2004 Jun;45(6):943-9. J Nucl Med. 2004. PMID: 15181128 Free article. Clinical Trial.

6

Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.

Weber B, Westera G, Treyer V, Burger C, Khan N, Buck A. Weber B, et al. J Nucl Med. 2004 Aug;45(8):1344-50. J Nucl Med. 2004. PMID: 15299060 Free article. Clinical Trial.

7

Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.

Saura H, Ogasawara K, Suzuki T, Kuroda H, Yamashita T, Kobayashi M, Terasaki K, Ogawa A. Saura H, et al. Cerebrovasc Dis. 2012;33(4):354-61. doi: 10.1159/000335836. Epub 2012 Mar 14. Cerebrovasc Dis. 2012. PMID: 22433127

8

Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.

Takeuchi R, Matsuda H, Yonekura Y, Sakahara H, Konishi J. Takeuchi R, et al. J Cereb Blood Flow Metab. 1997 Oct;17(10):1020-32. doi: 10.1097/00004647-199710000-00003. J Cereb Blood Flow Metab. 1997. PMID: 9346426 Clinical Trial.

9

Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.

Isozaki M, Arai Y, Kudo T, Kiyono Y, Kobayashi M, Kubota T, Kikuta K, Okazawa H. Isozaki M, et al. Ann Nucl Med. 2010 Jun;24(5):371-7. doi: 10.1007/s12149-010-0367-9. Epub 2010 Mar 18. Ann Nucl Med. 2010. PMID: 20238185 Clinical Trial.

10

Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.

Kuroda H, Ogasawara K, Suzuki T, Chida K, Aso K, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Kubo Y, Ogawa A. Kuroda H, et al. Clin Nucl Med. 2012 Mar;37(3):235-40. doi: 10.1097/RLU.0b013e31823ea69f. Clin Nucl Med. 2012. PMID: 22310248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

435 results

Results by year